ascopubs.org

A multicenter, non-randomized, controlled trial to evaluate the efficacy of surgery versus radiofrequency ablation for small hepatocellular carcinoma (SURF-Cohort Trial ...

Phase 1b results of a multicenter, randomized phase 1b/2 study of gemcitabine and cisplatin +/- CPI-613 as first-line therapy for patients with advanced biliary tract cancer (BilT-04). This is an ASCO ...
ascopubs.org

Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk

Detection of Early Human Papillomavirus–Associated Cancers by Liquid Biopsy This multicenter, prospective cohort study enrolled participants from three cancer genetics clinics—University of Southern ...
UroToday

ASCO 2026: PEAK-1: A Randomized, Double-Blind, Active-Control, Multicenter Phase 3 Trial of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients with ...

A randomized, double-blind, active-control, multicenter phase 3 trial of casdatifan and cabozantinib versus placebo and cabozantinib in patients with advanced clear cell RCC. Treatment options remain ...
PR Newswire

Vitestro Publishes Landmark Peer-Reviewed Multicenter Clinical Study of Autonomous Robotic Phlebotomy in Clinical Chemistry

EU multicenter ADOPT clinical trial demonstrates the performance, safety, and patient experience of the Aletta ® Autonomous Robotic Phlebotomy Device™ for diagnostic blood collection UTRECHT, The ...